Wright Investors Service’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Wright Investors Service's CRL Position: Q2 2018 in Review
Wright Investors Service sold out of Charles River Laboratories (CRL) in Q2 2018, closing a stake of 5,798 shares — an estimated $619K sold.
Wright Investors Service first reported a position in CRL in Q2 2014 and held it in 16 quarters. The position peaked at $777K in Q3 2017. 348 funds tracked by Wall St. Rank hold CRL as of Q2 2018.
- Wright Investors Service reported no remaining Charles River Laboratories position as of Q2 2018 after selling out during the quarter.
- Wright Investors Service sold 5,798 Charles River Laboratories shares in Q2 2018, an estimated $619K.
- Wright Investors Service first reported a position in Charles River Laboratories in Q2 2014 and held it in 16 quarters.
- Wright Investors Service's Charles River Laboratories position peaked at $777K in Q3 2017.
- 348 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2018.
Based on Wright Investors Service's 13F filing for Q2 2018, filed 2 Aug 2018.